GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » ROIC %

Awakn Life Sciences (XCNQ:AWKN) ROIC % : -3,917.76% (As of Apr. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Awakn Life Sciences's annualized return on invested capital (ROIC %) for the quarter that ended in Apr. 2024 was -3,917.76%.

As of today (2024-09-21), Awakn Life Sciences's WACC % is 14.20%. Awakn Life Sciences's ROIC % is -395.57% (calculated using TTM income statement data). Awakn Life Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Awakn Life Sciences ROIC % Historical Data

The historical data trend for Awakn Life Sciences's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences ROIC % Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
ROIC %
-174.03 -343.95 -114.33 -198.53

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.84 -275.58 -3,439.49 -5,181.54 -3,917.76

Competitive Comparison of Awakn Life Sciences's ROIC %

For the Biotechnology subindustry, Awakn Life Sciences's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's ROIC % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's ROIC % falls into.



Awakn Life Sciences ROIC % Calculation

Awakn Life Sciences's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jan. 2024 is calculated as:

ROIC % (A: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jan. 2023 ) + Invested Capital (A: Jan. 2024 ))/ count )
=-3.926 * ( 1 - 0% )/( (3.9 + 0.055)/ 2 )
=-3.926/1.9775
=-198.53 %

where

Awakn Life Sciences's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Apr. 2024 is calculated as:

ROIC % (Q: Apr. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2024 ) + Invested Capital (Q: Apr. 2024 ))/ count )
=-2.096 * ( 1 - 0% )/( (0.055 + 0.052)/ 2 )
=-2.096/0.0535
=-3,917.76 %

where

Note: The Operating Income data used here is four times the quarterly (Apr. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (XCNQ:AWKN) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Awakn Life Sciences's WACC % is 14.20%. Awakn Life Sciences's ROIC % is -395.57% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Awakn Life Sciences ROIC % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines